CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 438 enrolled
Drug / intervention
3D Laparoscopic Surgery +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02327481
NCT02327481N/ACompleted
CompareCT.gov

Randomized Controlled Trials Comparing Clinical Outcomes of 3D Versus 2D Laparoscopic Surgery for Gastric Cancer

Fujian Medical University·interventional·Posted Dec 30, 2014·Updated Apr 7, 2023

In Brief

A clinical study evaluating 3D Laparoscopic Surgery and 2D Laparoscopic Surgery for Stomach Neoplasms. Completed, enrolled 438 participants.

Detailed Summary

The purpose of this study is to explore the feasibility, safety, and efficacy of 3D Laparoscopic Surgery for Gastric Cancer. The patients with gastric adenocarcinoma (cT1-4aN0-3M0) were studied.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStomach Neoplasms
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 30, 2014
Enrollment StartJan 1, 2015
Primary CompletionApr 26, 2016
Study CompletionApr 26, 2021
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.5 years ago

Interventions

3D Laparoscopic Surgeryprocedure

After exclusion of T4b, bulky lymph nodes, or distant metastasis case by diagnostic laparoscopy, 3D laparoscopic gastrectomy will be performed with curative treated intent. The type of reconstruction will be selected according to the surgeon's experience.

2D Laparoscopic Surgeryprocedure

After exclusion of T4b, bulky lymph nodes, or distant metastasis case by diagnostic laparoscopy, 2D laparoscopic gastrectomy will be performed with curative treated intent. The type of reconstruction will be selected according to the surgeon's experience.